Tazarotene 0.045% Lotion for Moderate-to-Severe Acne in Male and Female Participants: A Phase II Post-hoc Analysis
J Clin Aesthet Dermatol. 2021;14(4):E53–E60. by Hilary E. Baldwin, MD; Lawrence J. Green, MD, FAAD; Leon Kircik, MD; Eric Pierre Guenin, PharmD, PhD, MPH; Anya Loncaric Forest, MS; and Radhakrishnan